A probe study of the safety, tolerability and immunogenicity of human immunodeficiency virus (HIV-1) gag DNA vaccine in healthy adults

Trial Profile

A probe study of the safety, tolerability and immunogenicity of human immunodeficiency virus (HIV-1) gag DNA vaccine in healthy adults

Discontinued
Phase of Trial: Phase I

Latest Information Update: 02 Oct 2007

At a glance

  • Drugs V 520 (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Oct 2007 Status change
    • 05 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top